Source-linked AI summary
Causal machine learning for predicting treatment outcomes
Stefan Feuerriegel, Dennis Frauen, Valentyn Melnychuk, Jonas Schweisthal, Konstantin Hess, Alicia Curth, Stefan Bauer, Niki Kilbertus, Isaac S. Kohane, Mihaela van der Schaar
TL;DR
Assessing treatment effectiveness supports patient safety and personalized decision-making. This Perspective describes causal ML’s ability to estimate individualized treatment effects and discusses reliable use and clinical translation, while highlighting risks of biased or incorrect predictions.
Problem
Assessing treatment effectiveness requires understanding when treatments are effective or harmful to support patient safety and personalized decision-making.
Method
The Perspective discusses causal ML methods for estimating individualized treatment effects and outlines considerations for reliable use and clinical translation.
Results
Causal ML offers potential for novel conclusions about treatment efficacy and safety, including variation in treatment effects across subpopulations.
Takeaways & Limitations
Individualized treatment-effect estimates can support more personalized clinical decision-making about treatment effectiveness and harm.
Takeaways & Limitations
Reliable use remains challenging because confounding can bias treatment-effect estimates or even reverse their sign, and clinical translation has barriers.
Abstract
from arXiv · showhide
Causal machine learning (ML) offers flexible, data-driven methods for predicting treatment outcomes including efficacy and toxicity, thereby supporting the assessment and safety of drugs. A key benefit of causal ML is that it allows for estimating individualized treatment effects, so that clinical decision-making can be personalized to individual patient profiles. Causal ML can be used in combination with both clinical trial data and real-world data, such as clinical registries and electronic health records, but caution is needed to avoid biased or incorrect predictions. In this Perspective, we discuss the benefits of causal ML (relative to traditional statistical or ML approaches) and outline the key components and steps. Finally, we provide recommendations for the reliable use of causal ML and effective translation into the clinic.
Main
Causal ML extends machine learning toward estimating treatment effects and predicting outcomes due to treatments, enabling more personalized understanding of when treatments help or harm. It uses experimental and real-world data but faces causal-inference challenges because potential outcomes are not all observed.
- Main: Causal ML can use randomized controlled trials, clinical registries, electronic health records, and other real-world data to estimate treatment effects.These data sources can generate clinical evidence when used appropriately.
- Main: Individualized treatment effects and personalized predictions of potential outcomes support treatment decisions tailored to patient profiles.The approach can help identify where treatments are effective, ineffective, or harmful.
- Main: Causal ML relies on concepts and assumptions including causal graphs, confounders, consistency, identifiability, positivity, SUTVA, and unconfoundedness.These terms describe causal structure, observed and potential outcomes, treatment overlap, and conditions for inferring causal quantities.
- Main: Causal ML estimates treatment effects or predicts patient outcomes attributable to treatments, unlike traditional ML risk scoring.Its targets include causal quantities such as average or conditional average treatment effects and potential outcomes.
- Main: Causal ML is difficult because a patient’s potential outcomes under treatments not received are unobservable and therefore missing from the data.This is the fundamental problem of causal inference underlying treatment-effect estimation.
Causal ML in medicine
Causal ML extends treatment-effect estimation by embedding flexible machine learning in a causal framework, enabling individualized predictions from experimental and observational data. Its benefits are greatest for complex data-generating processes and limited prior knowledge, but valid use depends on causal assumptions and adequate sample sizes.
- Causal ML versus traditional ML: Causal ML estimates treatment effects and potential outcomes rather than only predicting observed outcomes, addressing unobserved counterfactual outcomes.Individual treatment effects cannot be directly observed because each patient receives only one treatment.
- Causal framework: Treatment-effect estimation requires assumptions such as no unmeasured confounding and modeling the dependence among treatments, outcomes, and patient characteristics.Violating these assumptions can produce confounding bias and even reverse the estimated effect’s sign.
- Causal ML versus traditional statistics: Causal ML’s core improvement is generally how treatment questions are answered, using less rigid models to capture complex disease dynamics, pathophysiology, and pharmacology.Classical statistical models may be misspecified when parametric associations are unavailable or unrealistic, especially in high-dimensional electronic health records.
- Data and model choice: Causal ML can use randomized controlled trials, clinical registries, and electronic health records, including high-dimensional or unstructured data such as images, text, time series, and genetic data.The choice between classical and modern models depends on the setting: simpler models suit small samples, whereas flexible nonlinear models suit larger samples.
- Scope and trade-offs: Causal ML may have advantages when the data-generating process is complex and prior knowledge is limited, although it typically requires larger sample sizes.Nonlinear relationships and treatment-effect heterogeneity are not unique to causal ML, since classical models can incorporate prespecified nonlinearities.
- Causal ML in medicine: In medicine, causal ML supports personalized care by estimating treatment effects for individuals or subpopulations and identifying heterogeneity across patients.Applications include comparing survival under oncology treatment plans, accounting for drug-metabolism differences, and understanding where treatments are effective.
Workflow
The workflow defines the causal question, data, estimand, model, assumptions, and robustness checks needed to predict treatment outcomes reliably. It distinguishes average from individualized effects, binary from continuous treatments, and treatment effects from potential outcomes.
- The workflow begins by clearly defining the research question and then choosing the causal quantity, model, causal ML method, and robustness checks.
- Data and setup: Causal analyses require treatment, observed outcome, and patient-characteristic data, which may come from observational or experimental sources.Observational treatment assignment is not fully randomized and may depend on patient characteristics, whereas randomized trials determine assignment experimentally.
- Estimands: The estimand varies by effect heterogeneity—average treatment effect or conditional average treatment effect—and by treatment type, including binary, discrete, or continuous treatments.Continuous-treatment effectiveness may be summarized with dose-response curves.
- Potential outcomes: Potential outcomes describe hypothetical outcomes under specified treatments, while treatment effects quantify differences between potential outcomes.Predicted potential outcomes can provide absolute risks under each treatment, whereas treatment effects provide relative differences.
- Estimands: Average treatment effects describe population-level effectiveness, whereas CATEs describe effects for covariate-defined patient subgroups.CATEs can identify subgroups where treatments are ineffective or harmful, supporting individualized recommendations.
- Assumptions: Because counterfactual outcomes are unobservable, formal assumptions are required for identifiability and reliable treatment-effect inference.Without identifiability, treatment effects cannot be estimated without bias even with infinite data.
Technical recommendations
Reliable causal ML requires checking identifiability assumptions, assessing uncertainty and robustness, and interpreting results cautiously. Observational analyses are particularly dependent on domain knowledge, data quality, model choice, and transparent validation.
- Assumptions: Assessing the plausibility of identifiability assumptions is crucial for valid treatment-effect estimates.
- Positivity: Positivity violations can leave some patient subgroups without sufficient treatment support, so those subgroups may need exclusion from analysis.Propensity scores should be examined because values that are too small or large limit reliable inference.
- Unconfoundedness: Unconfoundedness is difficult to validate in real-world data and requires capturing relevant treatment-assignment factors using domain knowledge.Instrumental-variable approaches are possible, but valid instruments are often rare and their validity cannot be tested.
- Robustness: Sensitivity analysis estimates bounds under restrictions on unobserved confounding, while refutation methods probe robustness under explicit assumption violations.The appropriate refutation method depends on the specific problem setting.
- Robustness: Positive refutation results do not guarantee that the underlying causal assumptions are satisfied.
- Interpretation: Results should report assumptions, method rationale, robustness checks, uncertainty, and data limitations, with RWD estimates compared against RCT evidence when possible.Such comparisons can reveal differences between clinical trials and routine care caused by differing cohorts or adherence.
Clinical translation
Causal ML may extend clinical evidence beyond average trial effects by identifying heterogeneous responses and predicting outcomes for different treatment options. Translation requires cautious validation, uncertainty quantification, practical tools, and regulatory processes tailored to causal ML.
- Opportunities: Causal ML can analyze treatment-effect heterogeneity in registries and electronic health records, including for groups underrepresented in randomized trials.
- Clinical evidence: RCT-based causal ML may identify patient cohorts that respond positively or negatively to treatment, with antidepressant effects increasing with baseline depression severity.
- Opportunities: Real-world data with causal ML may support estimates for vulnerable groups, rare diseases, long-term outcomes, and uncommon side effects.
- Examples: Causal ML has been used with real-world data to estimate hospitalization effects on suicide risk when hospitalization cannot typically be randomized.
- Clinical decision-making: Estimand choice depends on the setting: ATE addresses population-level net benefit, whereas CATE addresses variation across subpopulations.
- Challenges: Clinical translation is limited by the difficulty of estimating heterogeneous effects and outcomes, the need for large samples, and insufficient uncertainty quantification.Point estimates can mistake large predictive uncertainty for treatment-effect heterogeneity, producing misleading conclusions.
- Future directions: Standardized protocols, ethical guidelines, checklists, review processes, and software supporting rigorous uncertainty quantification are needed for safe clinical use.
- Validation: Because simulations do not fully capture real-world disease dynamics, cautious proof-of-concept studies and comparisons with established clinical trials are needed.
Conclusion
Causal ML offers opportunities to draw conclusions about treatment efficacy and safety and to personalize treatment strategies. Reliable clinical use still requires robust methods, careful translation, and cautious practice.
- Causal ML offers potential for novel conclusions about treatment efficacy and safety and for personalizing treatment strategies.
- Clinical adoption must address the reliability and robustness of causal ML methods.
- Proof-of-concept studies and cautious use in practice are identified as an important first step toward clinical translation.